Literature DB >> 3471307

Abnormalities at chromosome region 3p12-14 characterize clear cell renal carcinoma.

P R Carroll, V V Murty, V Reuter, S Jhanwar, W R Fair, W F Whitmore, R S Chaganti.   

Abstract

In an effort to determine whether or not any characteristic chromosomal abnormalities exist in renal cancer, cytogenetic findings were correlated with tumor histology in nine cases of renal adenocarcinoma. Metaphase preparations adequate for analysis were obtained from cultures harvested between day 3 and day 21. Model chromosome number was diploid in three cases, hypodiploid in three, and hyperdiploid in the remaining three. One clear cell adenocarcinoma failed to reveal any chromosomal abnormality. Two tumors, a tubular/papillary carcinoma and an acinar/papillary carcinoma, showed the clonal abnormalities del(1)(p2l),+2,+7,+8,+12,+13,+16,+17,-21 and t(2;10)(q14-21;q26),+7q,+11q,-18, respectively. Interestingly, five of six clear cell tumors studied had clonal abnormalities affecting the short arm of chromosome #3 in the 3p12-21 region, and in the remaining case, of 15 karyotyped metaphases suitable for interpretation, one showed a deletion in 3p. These data indicate that clear cell carcinoma of the kidney may be associated with a nonrandom chromosomal abnormality involving the 3p12-14 region.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3471307     DOI: 10.1016/0165-4608(87)90059-8

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  15 in total

Review 1.  Application of molecular cytogenetic techniques to the evaluation of renal parenchymal tumors.

Authors:  G Kovacs
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  Transient ischaemic attack secondary to paraneoplastic erythrocytosis.

Authors:  Aldo René Hurtarte Sandoval; Bryan Josué Flores Robles; Robert Francis Andrus; David Alejandro Yaxcal Chon
Journal:  BMJ Case Rep       Date:  2014-10-21

3.  Papillary renal cell carcinoma. A morphologic and cytogenetic study of 11 cases.

Authors:  G Kovacs
Journal:  Am J Pathol       Date:  1989-01       Impact factor: 4.307

4.  Identification of rapid turnover transcripts overexpressed in thyroid tumors and thyroid cancer cell lines: use of a targeted differential RNA display method to select for mRNA subsets.

Authors:  R Gonsky; J A Knauf; R Elisei; J W Wang; S Su; J A Fagin
Journal:  Nucleic Acids Res       Date:  1997-10-01       Impact factor: 16.971

5.  Aristolochic Acid in the Etiology of Renal Cell Carcinoma.

Authors:  Margaret L Hoang; Chung-Hsin Chen; Pau-Chung Chen; Nicholas J Roberts; Kathleen G Dickman; Byeong Hwa Yun; Robert J Turesky; Yeong-Shiau Pu; Bert Vogelstein; Nickolas Papadopoulos; Arthur P Grollman; Kenneth W Kinzler; Thomas A Rosenquist
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-08-23       Impact factor: 4.254

6.  Localization of human ERBA2 to the 3p22----3p24.1 region of chromosome 3 and variable deletion in small cell lung cancer.

Authors:  H Drabkin; F T Kao; J Hartz; I Hart; A Gazdar; C Weinberger; R Evans; M Gerber
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

7.  Ultrastructural appearance and cytoskeletal architecture of the clear, chromophilic, and chromophobe types of human renal cell carcinoma in vitro.

Authors:  C D Gerharz; R Moll; S Störkel; U Ramp; W Thoenes; H E Gabbert
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

8.  A tumor suppressor locus within 3p14-p12 mediates rapid cell death of renal cell carcinoma in vivo.

Authors:  Y Sanchez; A el-Naggar; S Pathak; A M Killary
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

9.  Recurrent genomic rearrangements are not at the fragile sites on chromosomes 3 and 5 in human renal cell carcinomas.

Authors:  G Kovacs; P Brusa
Journal:  Hum Genet       Date:  1988-09       Impact factor: 4.132

10.  Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma.

Authors:  G Kovacs; R Erlandsson; F Boldog; S Ingvarsson; R Müller-Brechlin; G Klein; J Sümegi
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.